EPOCH
Overview[edit | edit source]
EPHB6 is a member of the ephrin receptor subfamily of the protein-tyrosine kinase family. These receptors and their ligands, the ephrins, are crucial for numerous developmental processes, particularly in the nervous system and in the formation of the vascular system. EPHB6 is unique among the Eph receptors because it lacks kinase activity, which suggests it may have distinct roles compared to other family members.
Structure[edit | edit source]
EPHB6 is a transmembrane protein that consists of an extracellular region, a single transmembrane segment, and a cytoplasmic domain. The extracellular region contains a ligand-binding domain, a cysteine-rich domain, and two fibronectin type III repeats. The cytoplasmic domain is atypical because it lacks the kinase activity that is characteristic of other Eph receptors.
Function[edit | edit source]
EPHB6 plays a role in cell adhesion and migration, which are critical processes in embryonic development and tissue organization. It is involved in the regulation of cell shape and movement, and it can influence the behavior of cells by interacting with other Eph receptors and ephrins. Despite its lack of kinase activity, EPHB6 can modulate signaling pathways by forming complexes with other kinases or by acting as a dominant-negative receptor.
Expression[edit | edit source]
EPHB6 is expressed in various tissues, including the thymus, brain, and certain epithelial tissues. Its expression is tightly regulated during development and can be altered in certain pathological conditions, such as cancer.
Clinical Significance[edit | edit source]
Alterations in EPHB6 expression have been associated with several types of cancer, including breast cancer and melanoma. In some cancers, EPHB6 expression is reduced, which may contribute to increased tumor invasiveness and metastasis. Understanding the role of EPHB6 in cancer could lead to new therapeutic strategies.
Research[edit | edit source]
Current research on EPHB6 focuses on its role in cancer biology, its potential as a therapeutic target, and its interactions with other proteins in signaling pathways. Studies are also exploring the role of EPHB6 in immune system function and its potential involvement in neurological disorders.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD